The State of Diabetes Research Across America
Clinical research in the U.S. is not one uniform experience. A trial in Miami will feel different from one in Boston, and the type of diabetes you have shapes which studies are even open to you. The landscape has shifted noticeably in recent years, with a heavy emphasis on a few distinct fronts.
Oral GLP-1 medications have become one of the most active areas of investigation. The ACHIEVE trials, presented at the American Diabetes Association's Scientific Sessions in New Orleans, demonstrated the benefits of orforglipron, the first oral, small-molecule GLP-1 receptor agonist to complete a phase 3 program. Meanwhile, AstraZeneca's SOLSTICE trial enrolled 406 adults with type 2 diabetes and reported dramatic improvements in blood sugar control and weight with a new oral medication. These findings matter because they suggest that the injections many people dread may eventually give way to simpler pill-based options.
Automated insulin delivery is another hot field. The STRIVE trial examined a next-generation Omnipod system in adults with type 2 diabetes, showing improvements in time spent in the target glucose range. Technology that once felt reserved for type 1 diabetes is now being studied for the far larger population living with type 2.
There is also a growing "food as medicine" movement. Research presented at ADA 2026 compared monthly grocery subsidies with medically tailored meal delivery. One study of roughly 1,000 patients found that simply giving people money to buy healthy food did not reliably move their A1C. But a separate trial from the University of North Carolina found that delivered medically tailored meals, paired with telephone lifestyle coaching, lowered A1C by about 0.4% more than grocery subsidies alone. The takeaway is subtle: access alone is not enough, but structured support works.
The Realities of Joining a Trial
Most people who join a diabetes trial are motivated by two things: access to cutting-edge care and compensation. Both are real, but both come with caveats worth understanding.
Compensation varies widely depending on the study's phase, length, and what it demands of you. Short observational studies may pay a few hundred dollars. Per-visit payments in some New York-based trials run around $125 per appointment. Longer phase 2 studies commonly range from a few hundred to several thousand dollars across the full duration. At the higher end, some residential trials in cities like Los Angeles have recruited participants with compensation reaching five figures. A good rule of thumb is that compensation should reflect the time, travel, and inconvenience involved, not be the sole reason you enroll.
Access to investigational treatments is genuinely valuable, particularly for people whose current regimen is not working well. Many trials provide the study drug or device at no cost, along with regular checkups, lab work, and specialist monitoring. For people without comprehensive insurance, this can meaningfully reduce out-of-pocket costs. Some trials also cover travel or provide meals during study visits.
That said, randomized trials carry a fundamental uncertainty. You may be assigned to the placebo or to a standard-of-care group rather than the new treatment. You will need to follow the study protocol, which can mean frequent clinic visits, wearing monitoring devices, logging meals, or adjusting medications in ways that disrupt your normal routine. Some studies, particularly early-phase ones, involve procedures or interventions that carry their own risks.
Consider how a typical study participant experiences this. Sarah, a 54-year-old teacher in Phoenix, joined a continuous glucose monitoring trial after struggling with unpredictable blood sugar swings on oral medications alone. The trial gave her a CGM device she could not otherwise afford, and the weekly check-ins with the study team helped her identify patterns her regular appointments had missed. The compensation of a few hundred dollars covered her gas and time off work. For her, the trial was a net win, even though she was in the standard-care arm. The experience is not universal, but it is representative of what good, well-run studies can offer.
A Practical Look at the Options
| Trial Focus | What It Involves | Typical Compensation | Best Fit For | Advantages | Considerations |
|---|
| Oral GLP-1 medication | Daily pill, regular A1C and weight checks | $300-$3,000+ across study | Type 2 patients seeking alternatives to injections | Pill form, potential weight loss | Random assignment, unknown side effects |
| Automated insulin delivery | Wearing a pump or hybrid system, CGM | $1,000-$5,000+ | Insulin-using type 2 and type 1 patients | Better time-in-range, less manual dosing | Learning curve, device wear burden |
| Continuous glucose monitoring | CGM sensor, regular data review | $200-$1,500 | Type 2 patients not on insulin | Real-time glucose insight | Requires consistent wear |
| Medically tailored meals | Delivered meals, lifestyle coaching | Compensation varies | Type 2 patients with food insecurity | Improves A1C and blood pressure | Requires following meal plan |
| Early-phase safety studies | Residential stays, frequent sampling | Often $2,000-$10,000+ | Generally healthy adults | Higher compensation | More invasive, higher time commitment |
How to Find and Evaluate a Trial Near You
Start with the official registry. ClinicalTrials.gov is the most comprehensive database of studies recruiting in the United States, and it lets you filter by condition, location, and recruitment status. The National Institute of Diabetes and Digestive and Kidney Diseases also maintains lists of federally sponsored trials, many of which recruit across multiple states.
Before reaching out to any site, read the eligibility criteria carefully. Most trials specify age ranges, A1C levels, current medications, and other health conditions that determine whether you qualify. If you have type 2 diabetes but the study is enrolling only type 1 patients, your time is better spent elsewhere.
When you find a promising trial, ask the study coordinator a focused set of questions. Which arm are you likely to be assigned to, and what does standard care look like in this study? What is the exact compensation schedule? Will the study cover travel or lost work time? What happens if you experience side effects or want to withdraw? Reputable sites will answer all of these clearly and in writing.
Verify the site's credentials. Legitimate research centers are affiliated with hospitals, universities, or established clinical research organizations, and their studies are registered on ClinicalTrials.gov. Be wary of anyone who pressures you to enroll quickly or who cannot clearly explain the study's purpose, duration, and risks. Compensation should never be described as the primary benefit of participation.
Also consider geography. Some trials, particularly residential early-phase studies, are concentrated in a handful of cities. If you live in a rural area, travel costs can eat into any compensation. Look for studies close to home first, and ask whether remote monitoring options are available, as some device and medication trials now allow participants to complete portions of the study from home.
A Word on Costs and Coverage
Clinical trial participation itself should not add to your medical bills. Investigational treatments, study devices, and protocol-required visits are typically provided by the sponsor. That does not mean every aspect of your diabetes care is covered, so ask what happens to your regular prescriptions and supplies during the study. Some trials require you to pause certain medications, and you want a clear picture of how the study team coordinates with your regular doctor.
If you are considering a glucose monitor, pump, or other device outside of a trial, the costs can be substantial. Insulin pump systems with integrated continuous glucose monitoring can run thousands of dollars out of pocket without coverage, and monthly supplies add up. Medically tailored meal programs and lifestyle interventions, meanwhile, are increasingly available through some health systems and insurers as part of broader diabetes management support. Asking your care team what is covered under your plan is often the fastest path to practical help.
Making the Decision That Fits Your Life
Diabetes management trials in the United States represent a genuine opportunity to access emerging treatments, receive close medical attention, and contribute to research that will shape care for millions. They are not a free ride, and they are not for everyone. The right trial can improve your glucose control and save you money on care you would otherwise pay for yourself. The wrong one can waste your time and add stress to an already demanding condition.
The sensible approach is to do your homework first. Understand your own numbers, your current regimen, and what you most want to improve. Then compare a few trials side by side, ask hard questions, and talk the decision over with your endocrinologist or primary care doctor. If you live with diabetes and feel like your current plan has hit a plateau, a well-matched trial might be exactly the reset you need. Take your time, verify everything, and choose the study that genuinely fits your health goals rather than the one that simply pays the most.
American Diabetes Association and NIDDK offer free resources to help you navigate your options, and your local academic medical center is usually a good starting point for learning what is recruiting in your area.
研究の知恵